PR92846

TAIZHOU, China, Nov. 4, 2021 /Xinhua=KYODO JBN/--

Recently, the 12th China (Taizhou) International Medical Expo was held in China

Medical City in Taizhou, China. Starting from the needs of normalized

prevention and control of the epidemic, this year's expo made an

"online+on-site" integrated exhibition, through the policy seminars, industry

summits, cutting-edge technology promotion, innovative product display, talent

exchanges, and roadshow activities. It will build a platform for international

exchanges and cooperation in the pharmaceutical and general health industries

to further gather innovative resources and talents and promote the accelerated

development of the biomedical health industry, according to the organizing

committee of China (Taizhou) International Medical Expo.

During the exhibition, China Medical City issued a series of preferential

policies for investment promotion, covering the fields of R&D, production,

sales, application, and increased support from the innovative development of

pharmaceutical companies, the development of project industrialization, and

high-level talents. At the scene, a total of 20 projects were contracted

collectively, with a total investment of 5.342 billion yuan.

China Medical City, located in Taizhou City, Jiangsu Province, has a planned

core area of 30 square kilometers, consisting of functional areas such as

scientific research and development zone, manufacturing zone, exhibition and

trading zone, health and health care zone, education and teaching zone, and

comprehensive supporting zone. Up to now, China Medical City has gathered more

than 1,200 well-known domestic and foreign pharmaceutical companies, including

14 well-known multinational companies such as AstraZeneca, Nestle, Takeda

Pharmaceuticals, Boehringer Ingelheim, and Arabindo; more than 2,100

"world-class, The domestically leading" pharmaceutical innovation results have

been applied for landing; more than 4,300 high-level talents at home and abroad

have settled in innovation and entrepreneurship.

After more than ten years of development, China Medical City has closely

focused on the two themes of "medicine" and "medicine", accelerated the

construction of characteristic industrial clusters, and basically formed

biological drugs (vaccine, antibody drugs), diagnostic reagents, high-end

medical devices, and chemical drugs. The "3+2" industry chain supported by the

three leading industries of new preparations, the special medical formula food

and the two characteristic industries of animal protection.

Source: China (Taizhou) International Pharmaceutical Expo Organizing Committee